Dec 16 (Reuters) - Bioretec Oy BRETEC.HE:
BIORETEC UPDATES ITS STRATEGY FOR 2026-2028 AND PROVIDES NEW FINANCIAL TARGETS
TARGETS NET SALES EXCEEDING EUR 10 MILLION BY 2028
AIMS TO MAINTAIN SALES MARGIN EXCEEDING 70%
PLANS TO INTRODUCE NEW PRODUCT EVERY 12–18 MONTHS
DOES NOT EXPECT TO REACH CASH FLOW POSITIVITY OR PROFITABILITY DURING STRATEGY PERIOD DUE TO PLANNED STRATEGIC INVESTMENTS IN RESEARCH AND DEVELOPMENT AND COMMERCIALIZATION
Source text: ID:nWkr5vQC7Q
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))